We have been developing 2-deoxy-D-glucose (2-DG), an analog of glucose, as a non-toxic anti-cancer agent and in an FDA-approved Phase
The following is a review of the literature and evidence supporting the anti-viral properties of 2-DG, lending further credence to our hypothesis that it can be used as a possible treatment for COVID-19. We are
Since 2-DG became available in Germany in 2018, The Lampidis Cancer Foundation has been actively collaborating with participating doctors and
Combining non-toxic glycolytic inhibitors with non-toxic antibiotics Although it has long been known that the anti-oxidant properties of vitamin C
In a recent publication titled 2-Deoxy-D-Glucose Inhibits Aggressive Triple-negative Breast Cancer Cells By Targeting Glycolysis And The Cancer Stem Cell
As reported in September, the Lampidis Cancer Foundation, along with the MCS Foundation for Life, has been actively collaborating with clinics worldwide on implementing protocols using 2-DG for patients who have failed standard treatment. The
An article published in the British journal Nature last week reports the anti-cancer activity of the naturally found sugar mannose.
Dr. Lampidis Collaborates on Groundbreaking 2-DG Clinical Trial in Germany We are delighted to announce today that the Lampidis Cancer
A group of Students for 2-DG, led by Kimi Lampidis, daughter of renowned cancer researcher Dr. Theodore Lampidis, have recorded
$1 is donated to the Lampidis Cancer Foundation for every prescription filled with this card. Present this card to your pharmacy for